Panacea Biotec · NSE: PANACEABIO · BSE: 531349
Q2 FY19 results · Jul–Sep 2018
Panacea Biotec reported revenue from operations of ₹118.58 crore and net loss of ₹97.49 crore for Q2 FY19 (Jul–Sep 2018), on a standalone basis.
| Item | Q2 FY19 | Q2 FY18 | YoY | Q1 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 118.58 | — | — | 95.11 | +24.7% |
| Other income | 3.30 | — | — | 3.33 | −0.9% |
| Total income | 121.88 | — | — | 98.44 | +23.8% |
| Profit before tax | (94.83) | — | — | (34.17) | Loss widened |
| Net profit for the period | (97.49) | — | — | (36.83) | Loss widened |
| EPS, basic (₹) | (15.92) | — | — | (6.01) | Loss widened |
| Net margin (%) | -82.2 | — | -38.7 |
Standalone
- Filed with BSE
- 24 Nov 2018, 11:05 IST
- Board meeting
- 14 Nov 2018
- Period
- 01 Jul 2018 to 30 Sep 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE